1. Blocking connexin43 hemichannels prevents TGF‐β2 upregulation and epithelial–mesenchymal transition in retinal pigment epithelial cells. (9th November 2021) Authors: Lyon, Heather; Yin, Naibo; Rupenthal, Ilva D.; Green, Colin R.; Mugisho, Odunayo O. Journal: Cell biology international Issue: Volume 46:Number 2(2022) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Blocking the inflammasome: A novel approach to treat uveitis. Issue 12 (December 2021) Authors: Shome, Avik; Mugisho, Odunayo O.; Niederer, Rachael L.; Rupenthal, Ilva D. Journal: Drug discovery today Issue: Volume 26:Issue 12(2021) Page Start: 2839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy. (January 2021) Authors: Louie, Henry H.; Shome, Avik; Kuo, Charisse YJ.; Rupenthal, Ilva D.; Green, Colin R.; Mugisho, Odunayo O. Journal: Experimental eye research Issue: Volume 202(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy. Issue 8 (August 2019) Authors: Mugisho, Odunayo O.; Green, Colin R.; Zhang, Jie; Acosta, Monica L.; Rupenthal, Ilva D. Journal: Drug discovery today Issue: Volume 24:Issue 8(2019) Page Start: 1627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Depot formulations to sustain periocular drug delivery to the posterior eye segment. Issue 8 (August 2019) Authors: Agban, Yosra; Thakur, Sachin S.; Mugisho, Odunayo O.; Rupenthal, Ilva D. Journal: Drug discovery today Issue: Volume 24:Issue 8(2019) Page Start: 1458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease. (3rd October 2019) Authors: Mugisho, Odunayo O.; Rupenthal, Ilva D.; Paquet-Durand, Francois; Acosta, Monica L.; Green, Colin R. Journal: Expert opinion on therapeutic targets Issue: Volume 23:Number 10(2019:Oct.) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The influence of hyperglycemia on the safety of ultrasound in retinal pigment epithelial cells. (5th January 2021) Authors: Kang, Heather; Yin, Naibo; Lyon, Heather; Rupenthal, Ilva D.; Thakur, Sachin S.; Mugisho, Odunayo O. Other Names: Sibirny Andrei guestEditor. Journal: Cell biology international Issue: Volume 45:Number 3(2021) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics. (February 2022) Authors: Mugisho, Odunayo O.; Green, Colin R. Journal: Experimental eye research Issue: Volume 215(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗